Showing Results for: All Investing Articles
Yesterday, shares of this leading provider of flow control products and services rose considerably, and MoneyShow's Jim Jubak, thinks the answer as to why, can be found in the fourth quarter trends. FLS
With a price-to-book ratio of 1, this stock—a featured buy in our model portfolio—is among the cheapest large banks in the world, suggests Briton Ryle of The Wealth Advisory. SAN
DRIP investing is a powerful tool for investing small amounts of money, says Chuck Carlson, editor of DRIP Investor, who highlights a number of reasons why dividend reinvestment plans can play an important role in long-term portfolio planning.
Among our favorite investing ideas for the year, we recommend two leading pharmaceutical stocks that are trading at attractive levels for long-term value investors, notes John Buckingham, editor of The Prudent Speculator. JNJ, LLY
We believe this is an ideal time to build positions in one of America's most reliable companies, says Roger Conrad in Conrad's Utility Investor. SO
First came Europe's promise to support the euro, then the US pledge to keep interest rates low, and yesterday it was announced that Japan's extending its unlimited loan program for another year, writes MoneyShow's Jim Jubak, who shares what gained off of the news. MTU, SMFG, 8803:JP, 8801:JP, NKY:IND
Darren Schuringa of Yorkville Capital explains the benefits of MLPs for growth and income investors, highlighting several diversified MLP funds as well as a trio of favorite master limited partnerships. APL, ATLS, YMLI, YMLP, OKE
Should you consider buying Bitcoins? Jay Taylor believes they could be one of the riskiest investments around. In Daily Profit, he offers three simple reasons to stay on the sidelines and not buy this virtual currency.
Our latest featured value recommendation spun-off its research-based prescription drug business at the beginning of 2013; it is now focused on nutritional products, diagnostic equipment, generic drugs, and medical devices, explains J. Royden Ward, editor of Cabot Benjamin Graham Value Investor. ABT